Tag: Morphosys
Dax extends consolidation – which brands are now offering support
Dusseldorf The Dax expands its consolidation. The leading German index closes about 0.6 percent lower at 14,261 points. Both in the course of trading on Wednesday and on Tuesday, the…
Dax extends consolidation – which brands are now offering support
Dusseldorf The Dax expands its consolidation. Because for Jochen Stanzl from the online broker CMC Markets, “the reason that many have been looking for to take profits after the strong…
Morphosys: Biotech pioneer in the crisis of confidence
Medical research (icon image) Morphosys share price still fails to recover. (Photo: IMAGO/Westend61) Frankfurt After failures at research partners and disappointing sales figures for its first own drug, the Munich…
Dax continues to rise and closes in the black – Morphosys shares crash almost 30 percent
An increase of 2500 points or the equivalent of 17 percent since the end of September, of which 700 points alone since Thursday afternoon: the Dax has climbed for six…
Dax continues to rise and closes in the black – Morphosys shares crash almost 30 percent
An increase of 2500 points or the equivalent of 17 percent since the end of September, of which 700 points alone since Thursday afternoon: the Dax has climbed for six…
Dax continues to rise – Morphosys shares fall almost 30 percent
An increase of 2500 points or 17 percent since the end of September, including 700 points since Thursday afternoon. The Dax has climbed for six weeks in a row, most…
Alzheimer’s drug gantenerumab disappointed in clinical studies
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The pharmaceutical company Roche and its German partner Morphosys have to accept a new setback in…
Alzheimer’s drug gantenerumab disappointed in clinical studies
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The pharmaceutical company Roche and its German partner Morphosys have to accept a new setback in…
Dax continues to rise – but investors should expect a breather
Dusseldorf The upward trend continues on the German stock market. The Dax climbed 0.2 percent to 14,254 points in the morning. The daily high is 14,330 points. The leading index…
Roche’s Alzheimer’s drug disappoints in clinical trials
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The Swiss pharmaceutical giant Roche has to cope with another research setback with a new Alzheimer’s…
Where short sellers bet on falling prices
price chart Short sellers are not yet sending a recovery signal for the stock market. (Photo: Taxi Japan/Getty Images) Dusseldorf The German stock market has already fallen a lot this…
Where short sellers bet on falling prices
price chart Short sellers are not yet sending a recovery signal for the stock market. (Photo: Taxi Japan/Getty Images) Dusseldorf The German stock market has already fallen a lot this…
Biontech in Australia: Research center & mRNA production facility planned
Production at Biontech The Mainz-based company opens further locations worldwide, now also in Australia. (Photo: dpa) Frankfurt Biontech wants to further globalize its research and production. As part of a…
New data from drug research expected in autumn
Alzheimer’s disease Protein deposits in the brain – so-called amyloid plaques – are one of the main characteristics of Alzheimer’s disease. Many of the drug candidates currently being researched aim…
Against which stocks in the Dax, MDax and SDax are particularly bets
Trading room of the Frankfurt Stock Exchange Investor sentiment is currently tarnished. (Photo: dpa) Dusseldorf The Dax has risen by almost ten percent within a month. The German leading index…
Against which stocks in the Dax, MDax and SDax are particularly bets
Trading room of the Frankfurt Stock Exchange Investor sentiment is currently tarnished. (Photo: dpa) Dusseldorf The Dax has risen by almost ten percent within a month. The German leading index…
German biotech companies: growth in a difficult environment
on the trail of genes Preparing a sample for genetic analysis: German biotech companies are in demand with investors. (Photo: IMAGO/Westend61) Frankfurt At first glance, investments in the German biotech…
So it is with the new Alzheimer’s therapy
Neurologist Alois Alzheimer, drug Aduhelm To date, there is no drug that can cure the disease. (Photo: Mauritius Images, Getty Images, REUTERS (M)) Frankfurt “Will there be a breakthrough in…
Analysts adjust price targets for German shares
Traders at the Frankfurt Stock Exchange The assessment of the German stock market has changed significantly since the beginning of the year. (Photo: dpa) Dusseldorf The war in Ukraine caused…
Investors are afraid of positioning themselves on the wrong side
Dax curve The low for the year so far is 12,438 points. (Photo: Bloomberg Creative/Getty Images [M]) Frankfurt The German stock market is currently lacking fresh impetus to move prices.…